{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:26:09Z","timestamp":1789838769759,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T00:00:00Z","timestamp":1671321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T00:00:00Z","timestamp":1671321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Desmopressin acetate (DPA) is a synthetic analogue of vasopressin used in the treatment of diabetes insipidus, bedwetting, hemophilia A, and elevated levels of urea in the blood. Sensitive and selective stability-indicating methods are needed to be developed and validated for its assay pure and pharmaceutical dosage forms in the presence of its degradation products as no method has been reported for its determination in the presence of its degradants. This work describes a comparative study of five simple stability-indicating spectrophotometric techniques for determination of DPA in presence of its acid-degradation products (acid-degradants) without prior separation. The proposed spectrophotometric techniques (First derivative, Derivative ratio, Ratio difference, Mean centering and Dual wavelength) were developed and validated according to ICH guidelines. Acid degradation was carried out with 0.1\u00a0N HCl; the acid-degradants were separated on TLC plates and the acidic degradation pathway was established by IR, H-NMR and MS techniques. The TLC method was based on the separation of DPA and its acid-induced degradation products on silica gel plates using methanol: water (80:20, v\/v) as a developing system and UV detection at 254\u00a0nm. All assay suggested\u00a0methods\u00a0were\u00a0successfully\u00a0applied\u00a0for\u00a0quantitation\u00a0of\u00a0DPA\u00a0in\u00a0pure and tablet forms.\u00a0They are\u00a0specific,\u00a0sensitive,\u00a0precise\u00a0and\u00a0accurate. They\u00a0showed good linearity in the concentration range of 1\u201314\u00a0\u00b5g\/mL with good correlation coefficients, and limit of detection (LOD) of 0.304, 0.274, 0.167, 0.248 and 0.199 and limit of quantitation (LOQ) of 0.920, 0.829, 0.506, 0.751 and 0.604) for each method, respectively. These methods were successfully applied for the simultaneous determination of DPA in its pure and tablet dosage form in the presence of its acid-degradants. The results obtained were statistically comparable with those of reported HPLC assay method; no significant differences were observed with relevance to accuracy and precision. All the methods are sensitive, selective and can be used for the routine analysis of DPA in its pure and dosage forms.<\/jats:p>","DOI":"10.1186\/s13065-022-00906-x","type":"journal-article","created":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T12:02:22Z","timestamp":1671364942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative study of extension area based methods for spectrophotometric determination of desmopressin acetate in the presence of its acid-induced degradation products"],"prefix":"10.1186","volume":"16","author":[{"given":"Khadiga M.","family":"Kelani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M. Wafaa","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal A.","family":"Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Morshedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,18]]},"reference":[{"key":"906_CR1","volume-title":"Martindale: the complete drug reference","author":"S Sweetman","year":"2009","unstructured":"Sweetman S. Martindale: the complete drug reference. 36th ed. London: The Pharmaceutical Press; 2009.","edition":"36"},{"key":"906_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/ddr.20159","volume":"67","author":"M Williams","year":"2006","unstructured":"Williams M. The Merck Index: an encyclopedia of chemicals, drugs, and biologicals. 14th Edition. Merck Inc., Whitehouse Station\/Rahway, New Jersey, October 2006. Cloth 0-911910-00X. $125. pp. 2564. Drug Dev Res. 2006;67:870. https:\/\/doi.org\/10.1002\/ddr.20159.","journal-title":"Drug Dev Res"},{"key":"906_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2265.1993.tb00990.x","volume":"38","author":"A Fjellestad-Paulsen","year":"1993","unstructured":"Fjellestad-Paulsen A, Hoglund P, Lundin S, Paulsen O. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin Endocrinol. 1993;38:177\u201382.","journal-title":"Clin Endocrinol"},{"key":"906_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1023\/A:1018973029651","volume":"10","author":"AH Kahns","year":"1993","unstructured":"Kahns AH, Buur A, Bundgaard H. Prodrugs of peptides. 18. Synthesis and evaluation of various esters of desmopressin (dDAVP). Pharm Res. 1993;10:68\u201374.","journal-title":"Pharm Res"},{"key":"906_CR5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1021\/mp500809f","volume":"12","author":"J Wang","year":"2015","unstructured":"Wang J, Yadav V, Smart AL, Tajiri S, Basit AW. Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs. Mol Pharm. 2015;12:966\u201373.","journal-title":"Mol Pharm"},{"issue":"3","key":"906_CR6","first-page":"163","volume":"59","author":"J Dudkiewicz-Wilczy\u0144ska","year":"2002","unstructured":"Dudkiewicz-Wilczy\u0144ska J, Snycerski A, Tautt J. Determination of the content of desmopressin in pharmaceutical preparations by HPLC and validation of the method. Acta Pol Pharm. 2002;59(3):163\u20138.","journal-title":"Acta Pol Pharm"},{"key":"906_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0378-5173(98)00377-9","volume":"178","author":"K Fredholt","year":"1999","unstructured":"Fredholt K, \u00d8stergaard J, Savolainen J, Friis GJ. \u03b1-Chymotrypsin-catalyzed degradation of desmopressin (d-DAVP): influence of pH, concentration and various cyclodextrins. Int J Pharm. 1999;178:223\u20139.","journal-title":"Int J Pharm"},{"key":"906_CR8","first-page":"221","volume":"75","author":"S Taghizadeh","year":"2013","unstructured":"Taghizadeh S, Mohamadnia F, Adlnasab L. Development and validation of a reversed-phase high-performance liquid chromatography method for determination of desmopressin in chitosan nanoparticles. Indian J Pharm Sci. 2013;75:221.","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"906_CR9","first-page":"69","volume":"4","author":"D Desai","year":"2016","unstructured":"Desai D, Shah D, Patel D. Development and validation of RP-HPLC method for desmopressin from polymeric nanoparticles. IAJPS. 2016;4(1):69\u201373.","journal-title":"IAJPS"},{"key":"906_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/bmc.2782","volume":"27","author":"S Esposito","year":"2013","unstructured":"Esposito S, Deventer K, T\u2019Sjoen G, Vantilborgh A, Van Eenoo P. Doping control analysis of desmopressin in human urine by LC-ESI-MS\/MS after urine dilapidation. Biomed Chromatogr. 2013;27:240\u20135.","journal-title":"Biomed Chromatogr"},{"key":"906_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2478\/acph-2020-0036","volume":"70","author":"B Kov\u00e1cs","year":"2020","unstructured":"Kov\u00e1cs B, Boda F, F\u00fcl\u00f6p I, Sz\u00e9kely-Szentmikl\u00f3si I, Kelemen \u00c9K, Kov\u00e1cs-De\u00e1k B, Sz\u00e9kely-Szentmikl\u00f3si B. HPLC method development for fampridine using analytical quality by design approach. Acta Pharm. 2020;70:465\u201382.","journal-title":"Acta Pharm"},{"key":"906_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1023\/A:1015397811161","volume":"19","author":"J Wang","year":"2002","unstructured":"Wang J, Wu D, Shen W-C. Structure-activity relationship of reversibly lipidized peptides: studies of fatty acid-desmopressin conjugates. Pharm Res. 2002;19:609\u201314.","journal-title":"Pharm Res"},{"key":"906_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jpha.2013.11.002","volume":"7","author":"SK Gudlawar","year":"2017","unstructured":"Gudlawar SK, Pilli NR, Siddiraju S, Dwivedi J. Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC\u2013MS\/MS. J Pharm Anal. 2017;7:196\u2013202.","journal-title":"J Pharm Anal"},{"key":"906_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0021-9673(96)00831-X","volume":"761","author":"J Jiskra","year":"1997","unstructured":"Jiskra J, Pac\u00e1kov\u00e1 V, Tich\u00e1 M, \u0160tul\u00edk K, Barth T. Use of capillary electrophoresis and high-performance liquid chromatography for monitoring of glycosylation of the peptides dalargin and desmopressin. J Chromatography A. 1997;761:285\u201396.","journal-title":"J Chromatography A"},{"key":"906_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.15171\/apb.2017.054","volume":"7","author":"N Upmanyu","year":"2017","unstructured":"Upmanyu N, Porwal PK. Assay of desmopressin acetate in nasal spray: development of validated pre column HPLC-fluorescence method. Adv Pharm Bull. 2017;7:451.","journal-title":"Adv Pharm Bull"},{"key":"906_CR16","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s00216-011-5697-5","volume":"402","author":"S Esposito","year":"2012","unstructured":"Esposito S, Deventer K, T\u2019Sjoen G, Vantilborgh A, Delbeke FT, Goessaert A-S, Everaert K, Van Eenoo P. Qualitative detection of desmopressin in plasma by liquid chromatography\u2013tandem mass spectrometry. Anal Bioanal Chem. 2012;402:2789\u201396.","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"906_CR17","first-page":"321","volume":"3","author":"LD Srinivas","year":"2005","unstructured":"Srinivas LD, Prasad Rao KVS, Sastry BS. Spectrophotometric determination of desmopressin acetate in pharmaceutical dosage form with citric acid acetic anhydride reagent. Int J Chem Sci. 2005;3(2):321\u20134.","journal-title":"Int J Chem Sci"},{"key":"906_CR18","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1248\/cpb.44.1238","volume":"44","author":"M Nakamura","year":"1996","unstructured":"Nakamura M, Kato Y, Hayakawa E, Ito K, Kuroda T. Electrochemical stability of desmopressin acetate during iontophoresis. Chem Pharm Bull. 1996;44:1238\u201341.","journal-title":"Chem Pharm Bull"},{"issue":"3","key":"906_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1248\/bpb.21.268","volume":"21","author":"M Nakakura","year":"1998","unstructured":"Nakakura M, Kato Y, Ito K. Safe and efficient transdermal delivery of desmopressin acetate by iontophoresis in rats. Biol Pharm Bull. 1998;21(3):268\u201371.","journal-title":"Biol Pharm Bull"},{"key":"906_CR20","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1021\/jp810309d","volume":"113","author":"D Libster","year":"2009","unstructured":"Libster D, Aserin A, Yariv D, Shoham G, Garti N. Concentration-and temperature-induced effects of incorporated desmopressin on the properties of reverse hexagonal mesophase. J Phys Chem B. 2009;113:6336\u201346.","journal-title":"J Phys Chem B"},{"key":"906_CR21","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.hrthm.2012.05.002","volume":"9","author":"ST Coffin","year":"2012","unstructured":"Coffin ST, Black BK, Biaggioni I, Paranjape SY, Orozco C, Black PW, Dupont WD, Robertson D, Raj SR. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 2012;9:1484\u201390.","journal-title":"Heart Rhythm"},{"key":"906_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.elecom.2011.06.012","volume":"13","author":"SY Chee","year":"2011","unstructured":"Chee SY, Flegel M, Pumera M. Regulatory peptides desmopressin and glutathione voltammetric determination on nickel oxide modified electrodes. Electrochem Commun. 2011;13:963\u20135.","journal-title":"Electrochem Commun"},{"key":"906_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jpba.2004.02.009","volume":"35","author":"M Getie","year":"2004","unstructured":"Getie M, Neubert RH. LC\u2013MS determination of desmopressin acetate in human skin samples. J Pharm Biomed Anal. 2004;35:921\u20137.","journal-title":"J Pharm Biomed Anal"},{"key":"906_CR24","first-page":"1","volume":"6","author":"KM Kelani","year":"2020","unstructured":"Kelani KM, Nassar AMW, Talaat WI, Morshedy SM. A recent validated synchronous spectrofluorimetric method in comparative to ratio derivative one for determination of desmopressin acetate in dosage form and biological fluids. J Pharm Anal Chem. 2020;6:1\u20139.","journal-title":"J Pharm Anal Chem"},{"key":"906_CR25","unstructured":"FDA guideline for industry. Analytical procedures and methods validation (draft guidance) 2000;65(FR 52776):52776\u201352777. Agency\/Docket Number: Docket No. 00D-1424 Document Number: 00-22143."},{"key":"906_CR26","unstructured":"International Conference on Harmonization (ICH) for Registration of Pharmaceuticals for Human Use (2003). Stability Testing of New Drug Substances and Products, ICH-Q1A(R2), International Conference on Harmonization, Geneva, Switzerland."},{"key":"906_CR27","unstructured":"International Conference on Harmonization, ICH Harmonized Tripartite Guideline. Validation of analytical procedure: text and methodology, Q2 (R1), Geneva: International Conference on Harmonization; 2005."},{"key":"906_CR28","volume-title":"35th revision: the national formulary. 30th ed (Standing order)","author":"The United States Pharmacopeia","year":"2011","unstructured":"The United States Pharmacopeia, 35th revision: the national formulary. 30th ed (Standing order). United States Pharmacopeial Convention, Rockville; 2011."},{"issue":"6","key":"906_CR29","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0731-7085(00)00371-X","volume":"23","author":"N Erk","year":"2000","unstructured":"Erk N. Quantitative analysis of chlorpheniramine maleate and phenylephrine hydrochloride in nasal drops by differential-derivative spectrophotometric, zero-crossing first derivative UV spectrophotometric and absorbance ratio methods. J Pharm Biomed Anal. 2000;23(6):1023\u201331.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"906_CR30","first-page":"4","volume":"2","author":"V Choudhari","year":"2010","unstructured":"Choudhari V, Kale A, Abnawe S, Kuchekar B, Gawli V, Patil N. Simultaneous determination of montelukast sodium and levocetirizine dihydrochloride in pharmaceutical preparations by ratio derivative spectroscopy. Int J PharmTech Res. 2010;2(1):4\u20139.","journal-title":"Int J PharmTech Res"},{"issue":"4","key":"906_CR31","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1155\/2010\/493027","volume":"7","author":"R Hajian","year":"2010","unstructured":"Hajian R, Shams N, Kaedi I. Application of ratio difference spectrophotometry for simultaneous determination of naphazoline and antazoline in eye drops. E-J Chem. 2010;7(4):1530\u20138.","journal-title":"E-J Chem"},{"issue":"2","key":"906_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.aca.2004.09.064","volume":"526","author":"A Afkhami","year":"2004","unstructured":"Afkhami A, Bahram M. Mean centering of ratio kinetic profiles as a novel spectrophotometric method for the simultaneous kinetic analysis of binary mixtures. Anal Chem Acta. 2004;526(2):211\u20138.","journal-title":"Anal Chem Acta"},{"issue":"1","key":"906_CR33","first-page":"29","volume":"6","author":"N Fernandes","year":"2008","unstructured":"Fernandes N, Nimdeo MS, Choudhar VP, Kulkarni V, Pande VV, Nikalje AG. Dual wavelength and simultaneous equation spectrophotometric methods for estimation of atenolol and indapamide in their combined dosage form. Int J Chem Sci. 2008;6(1):29\u201335.","journal-title":"Int J Chem Sci"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-022-00906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-022-00906-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-022-00906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T12:02:35Z","timestamp":1671364955000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-022-00906-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1186\/s13065-022-00906-x","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,18]]},"assertion":[{"value":"27 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}